Exhibit 99.1 Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com June 12, 2023 National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ) BSE Limited (Scrip Code: 500124) Dear Sirs, Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Sche ...

Dr Reddy's Laboratories Ltd (NYSE:RDY) Q4 2023 Earnings Conference Call May 10, 2023 10:00 AM ET Company Participants Richa Periwal - IR Gunupati Prasad - Co-Chairman Parag Agarwal - CFO Erez Israeli - CEO Conference Call Participants Balaji Prasad - Barclays Bank Surya Patra - PhillipCapital Damayanti Kerai - HSBC Cyndrella Carvalho - JM Financial Ankush Mahajan - Axis Securities Nitin Agarwal - DAM Capital Advisors Madhav Marda - FI Industries Tushar Manudhane - Motilal Oswal Financial Services Kunal Dham ...

Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q3 FY 2023 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. [Operator Instructions] Please note that this conference is being recorded. Richa Periwal All the discussion and analysis of this call will be based on the IFRS consolidated financial statements. To discuss the business performance an ...

Dr.Reddy's Financial Results Q3 FY23 Jan 25th, 2023 1 | January 25 | Q3 FY23 Press Meet th, 2023 | As per consolidated financial statements under IFRS Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical ...

Call Start: 09:00 January 1, 0000 10:05 AM ET Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2023 Earnings Conference Call October 28, 2022 09:00 ET Company Participants Amit Agarwal - Head of Investor Relations & Director of Finance Parag Agarwal - Chief Financial Officer Erez Israeli - Chief Executive Officer Conference Call Participants Tarang Agarwal - Old Bridge Capital Prakash Agarwal - Axis Capital Kunal Dhamesha - Macquarie Capital Damayanti Kerai - HSBC Surya Patra - Philip Capital Sameer Baisiwala ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______ DR. REDDY'S LABORATORIES LIMITED (Translation of registrant's name into English) 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India +91-40-49002900 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40 ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q1 2023 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Parag Agarwal - Chief Financial Officer Erez Israeli - Chief Executive Officer Conference Call Participants Saion Mukherjee - Nomura Anubhav Aggarwal - Credit Suisse Damayanti Kerai - HSBC Prakash Agarwal - Axis Capital Neha Manpuria - Bank of America Sameer Baisiwala - Morgan Stanley Surya Patra - Philip Capital Tarang A ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 June, 2022 Commission File Number 1-15182 DR. REDDY'S LABORATORIES LIMITED (Translation of registrant's name into English) 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India +91-40-49002900 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 | ¨ | | --- | --- | | OR | | | þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the Fiscal Year Ended March 31, 2022 | | | OR | | | ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | OR | | | ¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 O ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q4 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Gunupati Prasad - Co-Chairman & Managing Director Erez Israeli - Chief Executive Officer Parag Agarwal - Chief Financial Officer Conference Call Participants Kunal Dhamesha - Macquarie Neha Manpuria - Bank of America Surya Patra - Philip Capital Nikhil Mathur - HDFC Mutual Fund Prakash Agarwal - Axis Capital Sameer Baisiwa ...